Kevin Hern · BSX
Kevin Hern's BSX trades
- Transactions
- 7
- Buys / sells
- 0 / 7
- Disclosed range
- $133K – $345K
- Last filed
- 2026-09-25
BSX transactions reported by Kevin Hern
| Type | Owner | ||||
|---|---|---|---|---|---|
Boston Scientific Corporation Common Stock BSX | Sale | Joint | $50,001 - $100,000 | 2026-09-25 #20035491 | |
Boston Scientific Corporation Common Stock BSX | Sale | Joint | $50,001 - $100,000 | 2026-09-25 #20035491 | |
Boston Scientific Corporation Common Stock BSX | Sale | Dependent | $1,001 - $15,000 | 2026-09-25 #20035491 | |
Boston Scientific Corporation Common Stock BSX | Sale | Dependent | $1,001 - $15,000 | 2026-09-25 #20035491 | |
Boston Scientific Corporation Common Stock BSX | Sale | Dependent | $1,001 - $15,000 | 2026-09-25 #20035491 | |
Boston Scientific Corporation Common Stock BSX | Sale | Joint | $15,001 - $50,000 | 2026-09-25 #20035491 | |
Boston Scientific Corporation Common Stock BSX | Sale | Joint | $15,001 - $50,000 | 2025-11-16 #20033458 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
How long disclosure took
Days from trade date to filing date for 7 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 0
- 16–30 days
- 7
- 31–45 days
- 0
- Over 45 days
- 0
- Median / longest
- 22d / 25d
What Kevin Hern's BSX filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- Boston Scientific Corporation financials and filings
Audited SEC figures, what moves BSX, and primary sources.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
Sep 22, 2026
Meta jumped 11%. What must happen next to justify the price?A member research report on Meta’s AI rally: Muse, subscription economics, the cash-flow burden, legal costs and the earnings assumptions behind the new price.
Feb 23, 2026
Newmont and the gap between a gold rally and shareholder cashA February 23, 2026 historical cutoff tests whether portfolio simplification and cost control could turn stronger gold economics into cash.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchOther members of Congress who reported BSX
More tickers reported by Kevin Hern
Kevin Hern and BSX — questions
Did Kevin Hern buy or sell BSX?
House Clerk filings for 2025 and 2026 show 0 purchases and 7 sales of Boston Scientific Corporation (BSX) reported by Kevin Hern, between 2025-10-28 and 2026-09-09. Reported owners: Joint, Dependent.
How much BSX did Kevin Hern trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $133K – $345K across 7 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last BSX filing by Kevin Hern?
The most recent periodic transaction report containing a BSX row was filed on 2026-09-25. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Boston Scientific Corporation. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Kevin Hern BSX disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included